Sabinsa Gains Patent for TetraPure Natural Antifungal Alternative
TetraPure is effective against a wide range of fungi such as Pityriasis versicolor, Seborrhoeic dermatitis, dandruff, Follicular pityriasis, Tinea nigra, white piedra, black piedra, and onychomycosis.
Sabinsa (East Windsor, NJ) has been granted a U.S. patent (#US8119696) for TetraPure, an antifungal ingredient for hair, skin, and nail care products that can be a natural replacement for antifungal agents and topical steroids. The patent is the company’s 70th patent.
According to the company, approximately 90% of fungal skin infections are caused by parasitic fungi that affect the skin, hair, and nails. (Antibiotics can also increase the incidence of fungal infections.)
As a natural alternative, TetraPure can be used in cream, shampoo, ointment, lotion, spray, or powder form for topical applications for the hair, skin, and nails. It is effective against a wide range of fungi such as Pityriasis versicolor, Seborrhoeic dermatitis, dandruff, Follicular pityriasis, Tinea nigra, white piedra, black piedra, and onychomycosis, relieving skin discomfort and soothing redness, irritation, scaling, itching, and burning.
Rousselot to showcase new collagen peptide research and targeted solutions at Vitafoods Europe 2024
April 25th 2024The company will be highlighting new research that demonstrates the ability of its Peptan collagen peptide brand to support sleep quality, reduce gastrointestinal discomfort, and enhance skin health, including density, hydration, and elasticity.
